(2-Isopropylthiazol-4-yl)methanamine dihydrochloride, 95.0%, 1g

(4aR,8aR)-Ethyl 7-oxooctahydro-2H-pyrano[3,2-c]pyridine-4a-carboxylate, 95%, 1g

Phthaloyl Amlodipine>98.0%(HPLC)(N)5g

3-Amino-4-(trifluoromethyl)benzonitrile, 95.0%, 1g

4-Fluoro-3-(trifluoromethyl)benzaldehyde, 97.0%, 10g

Pipette à déplacement direct MICROMAN® E, 10 à 100 µl, 1 pièce

Methyl 2-aminopyrimidine-5-carboxylate, 95.0%, 1g

1-methyl-2-oxo-1,2-dihydro-3-pyridinecarbaldehyde, 95.0%, 10g

(5-Chloro-2-(2-(methylamino)thiazol-4-yl)pyridin-4-yl)(4-(4-chlorobenzyl)piperazin-1-yl)methanone, 98.0%, 100mg

ATRASENTAN HYDROCHLORIDE, 95%, 100mg

(3-Methyl-2-furyl)methanol, 97.0%, 100mg

3-Tolualdehyde, 97.0%, 1g

(1S)-(-)-alpha-Pinene>97.0%(GC)500mL